Table 1.
The Baseline Characteristics Between EBS and PTBD in Patients with Bismuth Types III–IV
| Characteristic | EBS (n=97) | PTBD (n=48) | P value |
|---|---|---|---|
| Age (years) | 62 | 58 | 0.099 |
| Gender (n, %) | 0.509 | ||
| Male (n, %) | 53 (54.6%) | 29 (60.4%) | |
| Female (n, %) | 44 (45.4%) | 19 (39.6%) | |
| ECOG performance status (n, %) | 0.857 | ||
| 2 | 51 (52.6%) | 26 (54.2%) | |
| 3–4 | 46 (47.4%) | 22 (45.8%) | |
| TNM (n, %) | 0.867 | ||
| I–II | 27 (27.8%) | 14 (29.2%) | |
| III–IV | 70 (72.2%) | 34 (70.8%) | |
| Bismuth (n, %) | 0.677 | ||
| III | 31 (32.0%) | 17 (35.4%) | |
| IV | 66 (68.0%) | 31 (64.6%) | |
| TBIL (µmol/L) | 181.75 | 227.80 | 0.078 |
| AST (U/L) | 81.90 | 83.65 | 0.979 |
| ALT (U/L) | 68.30 | 88.15 | 0.329 |
| CA199 (U/mL) | 348.10 | 607.95 | 0.275 |
| CEA (µg/L) | 3.67 | 4.26 | 0.782 |